Maria T. Viscomi
Rome, 00168, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Transcranial magnetic stimulation recalibrates levodopa response by attenuating neuroinflammation and glial reactivity in experimental parkinsonism.
Journal: Experimental neurology
Published: January 19, 2026
T cells contribute to approaching positive but potentially risky stimuli through medial prefrontal cortex immune modulation.
Journal: Brain, behavior, and immunity
Published: January 11, 2026
Backtracking α-synuclein pathology: social deficits precede motor symptoms in Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: June 16, 2025
The oxytocin system mediates behavioral and neurobiological alterations associated with early adversity.
Journal: Molecular psychiatry
Published: May 10, 2025
GABAergic MicroRNA-34a in the Dorsal Raphe Nuclei Contributes to Circulating MicroRNA-34a Levels.
Journal: Molecular neurobiology
Published: May 06, 2025
Glia and semaphorins in neurodegenerative diseases: The frontier for new therapeutics.
Journal: Neural regeneration research
Published: February 18, 2025
Immune control of the basal ganglia network: Interleukin-17 as a key modulator of striatal synaptic plasticity.
Journal: Neurobiology of disease
Published: February 02, 2025
Oligomeric alpha-synuclein causes early synaptic dysfunction of the corticostriatal pathway associated with non-motor symptoms.
Journal: NPJ Parkinson's disease
Published: January 14, 2025
Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer's Disease.
Journal: Molecular neurodegeneration
Published: January 13, 2025
Glia-glia crosstalk via semaphorins: Emerging implications in neurodegeneration.
Journal: Ageing research reviews
Published: October 09, 2024
Neuropilin1-dependent paracrine signaling of cancer cells mediated by miRNA exosomal cargo.
Journal: Cell communication and signaling : CCS
Published: July 22, 2024
Hepatocyte delivery of miR-34b/c reduces hepatic stellate cell activation and improves liver fibrosis.
Journal: Molecular therapy. Nucleic acids
Published: July 21, 2024
Last Updated: 09/26/2026